Lot documentation is pending
We show no result for this exact configuration while its lot-specific report is unavailable.
Browse the COA library
Purity:99.81% by HPLC
In stock 
Package image for the selected configuration.
GLP-2 (TZ) 30 mg
A dual GIP and GLP-1 receptor agonist research peptide in exact 10 mg and 30 mg configurations.
Available to verified research accountsExact-SKU documentationLaboratory research use only
The U.S. Food and Drug Administration has not evaluated statements on this site. Stack Research products are not intended to diagnose, treat, cure, or prevent any disease or medical condition.
Lab results for the selected configuration
The published laboratory report covers this exact lot.
- Exact SKU
- STK-T30
- Lot
- 1056
- Laboratory
- Accumark Labs
- Report ID
- F2NZ-WYSS
- Sample received
- 2026-06-04
- Published
- June 9, 2026
IdentityConforms
HPLC purity99.81% by HPLC
Measured content32.25 mg measured
Bacterial endotoxinPass
SterilityNot detected
Read the complete laboratory report
Open full report
Open the PDF to read every page in the lot-specific report.
Documentation is pending for this exact SKU
We show no purity, identity, content, or contaminant result until a lot-specific report is available.
About GLP-2 (TZ)
The independent literature linked below uses the name tirzepatide and studies dual activity at GIP and GLP-1 receptors. The selected publications are human clinical studies and must be read within their stated designs, populations, comparators, and limits.
Stack Research supplies this product only for lawful in-vitro laboratory or analytical research. The independent literature linked on this page does not test this vial, and it provides no instructions for human or veterinary use.
Configuration and documentation
The configuration selected above controls the exact SKU, package image, and lot report shown on this page.
Research-use boundary
This page does not provide dosing, administration, treatment, diagnostic, or human-outcome guidance.
Product specifications
- Available configurations
- 10 mg / 30 mg
- Composition
- Dual agonist research peptide
- Documentation
- Lot-specific COA published for this exact SKU.
Research & literature
The publications below discuss the named compound. Only the lot report above evaluates the Stack Research product.
A paper's findings do not establish the identity, purity, safety, or intended use of this product.
Search PubMed for GLP-2 (TZ) (opens in a new tab)- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. Frías JP et al. · New England Journal of Medicine · 2021 PMID: 34170647 (opens in a new tab)
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Rosenstock J et al. · The Lancet · 2021 PMID: 34186022 (opens in a new tab)
Mechanism & research background
The selected clinical papers study tirzepatide as a dual GIP and GLP-1 receptor agonist. They report controlled human trials and should be read within their stated populations, comparators, and endpoints.
The publications below discuss the named compound. Only the lot report above evaluates the Stack Research product.
Researchers should read each linked paper for its model, methods, and limits. The cited literature does not supply instructions for this product.
Frequently asked questions
What does “dual agonist” refer to?
The selected tirzepatide literature describes activity at both GIP and GLP-1 receptors. That pharmacology term does not establish the composition or activity of this vial.
What kind of evidence is linked for GLP-2 (TZ)?
The selected sources are controlled human trials. Their findings apply to the study products, populations, comparators, doses, and endpoints described by the authors.
Is a lot report available for the selected configuration?
A current lot report covers exact SKU STK-T30, lot 1056, from Accumark Labs.
Does the selected configuration control the report shown?
Yes. Choosing a configuration updates every SKU-specific field and its linked lot report as one set.
Do the cited papers verify this vial?
No. The papers describe independent research. The lab-results section above contains the lot-specific evidence for this Stack Research product.
Do the studies cover the full GLP-2 (TZ) formulation?
The publications below discuss the named compound. Only the lot report above evaluates the Stack Research product.
Can this page guide human or veterinary use?
No. Stack Research supplies this product for laboratory research only. This page provides no dosing, administration, treatment, or diagnostic guidance.
Can researchers open the original sources?
Yes. Each citation opens its PubMed record. The search link above opens the complete product-specific query.
More to explore
Browse other products currently listed in the Stack Research catalog.
GLP-1 (SE)
Research peptides · 5 mg / 10 mg View product
GLP-3 (RT)
Research peptides · 10 mg / 30 mg View product
BPC-157
Research peptides · 5 mg / 10 mg View product
TB-500
Research peptides · 10 mg View product
TA-1 (Thymosin Alpha-1)
Research peptides · 10 mg View product
Sermorelin
Research peptides · 5 mg View product
Tesamorelin
Research peptides · 10 mg View product
Ipamorelin
Research peptides · 5 mg View product
Need documentation for GLP-2 (TZ)?
Send the exact SKU and lot so support can trace the applicable product record.